drugset / Trial / NCT02709928

Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects

NCT02709928 ↗

Phase 1 Completed 50 enrolled Theravance Biopharma
RandomizedParallel-groupDouble-blindBasic science

Summary

Multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TD-0714 in healthy adult and elderly subjects

Timeline

Start
2016-03
Primary completion
2016-11
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject TD-0714 Unknown — —

Indications

No indication recorded.